Santhera Pharmaceuticals
SANN.SW
#7954
Rank
C$0.31 B
Marketcap
$24.85
Share price
3.49%
Change (1 day)
74.51%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -$47.20

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$17.50. In 2022 the company made an earnings per share (EPS) of -$17.50 an increase over its 2021 EPS that were of -$24.56.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-$17.50-28.75%
2021-$24.56-69.23%
2020-$79.83222.64%
2019-$24.74-77.65%
2018-$110.71-5.34%
2017-$116.9552.2%
2016-$76.84-593.67%
2015$15.56-165.72%
2014-$23.68-2.15%
2013-$24.20-81.35%
2012-$129.8015.64%
2011-$112.24145.81%
2010-$45.66-53.37%
2009-$97.92-152.24%
2008$187.44-270.36%
2007-$110.02-33.09%
2006-$164.44